ProfileGDS4132 / 203020_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 18% 16% 18% 23% 21% 23% 21% 19% 21% 20% 23% 29% 32% 33% 27% 28% 28% 38% 23% 23% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10138.52218
GSM201543Muscle PCOS pioglitazone 12127.503316
GSM201544Muscle PCOS pioglitazone 16139.376218
GSM201545Muscle PCOS pioglitazone 20160.746823
GSM201829Muscle PCOS pioglitazone 23149.388621
GSM201830Muscle PCOS pioglitazon 25153.063223
GSM201831Muscle PCOS pioglitazone 27143.031421
GSM201832Muscle PCOS pioglitazone 3141.875619
GSM201833Muscle PCOS pioglitazone 4144.31721
GSM201834Muscle PCOS pioglitazone 8140.244120
GSM201835Muscle PCOS after pioglitazone 10240.472623
GSM201836Muscle PCOS after pioglitazone 12260.672629
GSM201837Muscle PCOS after pioglitazone 16264.471832
GSM201838Muscle PCOS after pioglitazone 20272.821933
GSM201839Muscle PCOS after pioglitazone 23259.690327
GSM201840Muscle PCOS after pioglitazone 25264.437528
GSM201841Muscle PCOS after pioglitazone 27254.696728
GSM201842Muscle PCOS after pioglitazone 3279.923938
GSM201843Muscle PCOS after pioglitazone 4252.310423
GSM201844Muscle PCOS after pioglitazone 8249.737223